Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway.
Bjune G, Høiby EA, Grønnesby JK, Arnesen O, Fredriksen JH, Halstensen A, Holten E, Lindbak AK, Nøkleby H, Rosenqvist E, et al.
Bjune G, et al. Among authors: rosenqvist e.
Lancet. 1991 Nov 2;338(8775):1093-6. doi: 10.1016/0140-6736(91)91961-s.
Lancet. 1991.
PMID: 1682541
Clinical Trial.